123
Participants
Start Date
June 2, 2023
Primary Completion Date
August 29, 2025
Study Completion Date
August 29, 2025
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
iResearch Atlanta, Decatur
Sky Clinical Research Network Group P.C., Union City
CenExel iResearch, LLC, Savannah
Clinical Neuroscience Solutions - Orlando, Jacksonville
Accel Research Sites - Maitland, Maitland
CNS Healthcare - Orlando, Orlando
South Florida Research Phase I-IV INC, Miami Springs
Accel Research Sites - Lakeland, Lakeland
Clinical Neuroscience Solution, Inc, Memphis
Boeson Research, Missoula
St Charles Psychiatric Associates & Midwest Research Group, Saint Charles
Alivation Research, LLC, Lincoln
DelRicht Research - Touro Medical Center, New Orleans
Preferred Research Partners (PRP), Little Rock
AIM Trials, Plano
Houston Clinical Trials, Bellaire
Flourish Research, San Antonio
IMMUNOe International Research Center, Centennial
Center For Psychiatry and Behavioral Medicine Inc, Las Vegas
Advanced Research Center (ARC), Anaheim
Collaborators (3)
Premier Research Group plc
UNKNOWN
Prometrika, LLC
INDUSTRY
Almac
INDUSTRY
Worldwide Clinical Trials
OTHER
Corium, Inc.
INDUSTRY